Available EU DMF/CEP
EU DMF
CEP
API Status
Commercial
Pipeline
Therapeutic Category
Alimentary tract & metabolism
Anti-infectives for systemic use
Antipyretic, analgesic and anti-inflammatory
Antineoplastic & immunomodulating agents
Blood & blood forming organs
Cardiovascular system
Genito-urinary system & sex hormones
Injectable forms
Musculo-skeletal system
Nervous system
Opthalmological preparations
Respiratory system
Available US DMF
US DMF
Additional DMF
Japanese DMF
Chinese DMF
Korean DMF
Injectable Forms
Yes
No
Sort By
Alphabetical
Therapeutic Category
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
'
'

Therapeutic Area

Polymorphic form

CAS No.

a
Acenocoumarol

Therapeutic Area

Cardiovascular system

Polymorphic form

CAS No.

152-72-7

Acetazolamide

Therapeutic Area

Cardiovascular system

Polymorphic form

Form II

CAS No.

59-66-5

Alendronate sodium

Therapeutic Area

Musculo-skeletal system

Polymorphic form

Trihydrate

CAS No.

121268-17-5

Aniracetam

Therapeutic Area

Nervous system

Polymorphic form

Monoclinic form

CAS No.

72432-10-1

Apixaban

Therapeutic Area

Blood & blood forming organs

Polymorphic form

Crystalline form N-1

CAS No.

129722-12-9

Apremilast

Therapeutic Area

Musculo-skeletal system

Polymorphic form

Form B

CAS No.

608141-41-9

Aripiprazole

Therapeutic Area

Nervous system

Polymorphic form

Type I

CAS No.

129722-12-9

Aripiprazole monohydrate non-sterile

Therapeutic Area

Nervous system

Polymorphic form

Monohydrate

CAS No.

851220-85-4

Aripiprazole monohydrate sterile

Therapeutic Area

Nervous system

Polymorphic form

Monohydrate

CAS No.

Avanafil

Therapeutic Area

Genito-urinary system & sex hormones

Polymorphic form

Crystalline, none

CAS No.

330784-47-9

b
Baclofen

Therapeutic Area

Musculo-skeletal system

Polymorphic form

Form B

CAS No.

1134-47-0

Baricitinib

Therapeutic Area

Antineoplastic & immunomodulating agents

Polymorphic form

Anhydrous crystalline form I

CAS No.

1187594-09-7

Brexpiprazole

Therapeutic Area

Nervous system

Polymorphic form

Polymorphic form I

CAS No.

913611-97-9

c
Carbamazepine

Therapeutic Area

Nervous system

Polymorphic form

Form III

CAS No.

298-46-4

Carvedilol

Therapeutic Area

Cardiovascular system

Polymorphic form

Form II

CAS No.

72956-09-3

Carvedilol phosphate hemihydrate

Therapeutic Area

Cardiovascular system

Polymorphic form

Form I

CAS No.

610309-89-2

Clopamide

Therapeutic Area

Cardiovascular system

Polymorphic form

Polymorphic form

CAS No.

636-54-4

d
Dabigatran etexilate mesylate

Therapeutic Area

Blood & blood forming organs

Polymorphic form

Form I

CAS No.

872728-81-9

Dapagliflozin

Therapeutic Area

Alimentary tract & metabolism

Polymorphic form

Amorphous

CAS No.

461432-26-8

Dapagliflozin propanediol monohydrate

Therapeutic Area

Alimentary tract & metabolism

Polymorphic form

Crystalline SC-3

CAS No.

960404-48-2

e
Elagolix sodium

Therapeutic Area

Genito-urinary system & sex hormones

Polymorphic form

Amorphous form

CAS No.

832720-36-2

Empagliflozin

Therapeutic Area

Alimentary tract & metabolism

Polymorphic form

Crystalline anhydrous

CAS No.

864070-44-0

Etodolac

Therapeutic Area

Musculo-skeletal system

Polymorphic form

Crystalline racemate, none

CAS No.

41340-25-4

h
Hydrochlorothiazide

Therapeutic Area

Cardiovascular system

Polymorphic form

Form I

CAS No.

58-93-5

i
Ibandronate sodium

Therapeutic Area

Musculo-skeletal system

Polymorphic form

Monohydrate Form B

CAS No.

138926-19-9

l
Lamotrigine

Therapeutic Area

Nervous system

Polymorphic form

Anhydrous monoclinic

CAS No.

84057-84-1

Linagliptin

Therapeutic Area

Alimentary tract & metabolism

Polymorphic form

Mix of form A & B

CAS No.

668270-12-0

n
Nefopam hydrochloride*

Therapeutic Area

Nervous system

Polymorphic form

CAS No.

23327-57-3

o
Opipramol dihydrochloride

Therapeutic Area

Nervous system

Polymorphic form

Amorphous

CAS No.

909-39-7

Oxcarbazepine

Therapeutic Area

Nervous system

Polymorphic form

Form A

CAS No.

28721-07-5

p
Pentoxifylline

Therapeutic Area

Cardiovascular system

Polymorphic form

Form I

CAS No.

1677687

Phenyl salicylate

Therapeutic Area

Antipyretic, analgesic and anti-inflammatory

Polymorphic form

Crystalline orthorhombic form

CAS No.

118-55-8

Pimavanserin tartrate

Therapeutic Area

Nervous system

Polymorphic form

Crystalline anhydrous form C

CAS No.

389574-19-0

Piracetam

Therapeutic Area

Nervous system

Polymorphic form

Form II

CAS No.

7491-74-9

r
R-Baclofen *

Therapeutic Area

Musculo-skeletal system

Polymorphic form

Form B

CAS No.

69308-37-8

R-Baclofen hydrochloride *

Therapeutic Area

Musculo-skeletal system

Polymorphic form

Crystalline HCl form

CAS No.

63701-55-3

Risedronate sodium

Therapeutic Area

Musculo-skeletal system

Polymorphic form

Form A

CAS No.

115436-72-1

Rivaroxaban

Therapeutic Area

Blood & blood forming organs

Polymorphic form

Modification I

CAS No.

366789-02-8

s
Sacubitril/Valsartan Complex

Therapeutic Area

Cardiovascular system

Polymorphic form

Crystalline

CAS No.

171599-83-0

Safinamide methanesulfonate*

Therapeutic Area

Nervous system

Polymorphic form

Crystalline anhydrous form A1

CAS No.

202825-46-5

Salicylamide

Therapeutic Area

Antipyretic, analgesic and anti-inflammatory

Polymorphic form

Monoclinic form with space group 12/a

CAS No.

65-45-2

Sildenafil citrate

Therapeutic Area

Genito-urinary system & sex hormones

Polymorphic form

Anhydrous Form 2

CAS No.

171599-83-0

Sitagliptin hydrochloride

Therapeutic Area

Alimentary tract and metabolism

Polymorphic form

Polymorphic form III

CAS No.

486459-71-6

Sodium salicylate

Therapeutic Area

Antipyretic, analgesic and anti-inflammatory

Polymorphic form

Monoclinic form (space group P21/m)

CAS No.

54-21-7

Solifenacin succinate

Therapeutic Area

Genito-urinary system & sex hormones

Polymorphic form

Form I

CAS No.

242478-37-1

t
Tadalafil

Therapeutic Area

Genito-urinary system & sex hormones

Polymorphic form

Form A (form I)

CAS No.

171596-29-5

Ticagrelor

Therapeutic Area

Blood & blood forming organs

Polymorphic form

Form II

CAS No.

274693-27-5

Tolterodine tartrate

Therapeutic Area

Genito-urinary system & sex hormones

Polymorphic form

Crystalline Form 1

CAS No.

124937-52-6

Topiramate

Therapeutic Area

Nervous system

Polymorphic form

Orthorhombic structure

CAS No.

97240-79-4

v
Vardenafil hydrochloride

Therapeutic Area

Genito-urinary system & sex hormones

Polymorphic form

Trihydrate form

CAS No.

330808-88-3

x
Xylometazoline hydrochloride*

Therapeutic Area

Respiratory system

Polymorphic form

CAS No.

1218-35-5

z
Zoledronic acid

Therapeutic Area

Musculo-skeletal system

Polymorphic form

Monohydrate

CAS No.

165800-06-6

Disclaimer
The above list is presented solely for informational purposes and does not constitute an offer in any sense. Products with PIPELINE & EARLY DEVELOPMENT STATUS under patent (SPC) protection in Poland and/or other countries are not offered until expiration of the corresponding IP right.

Products with COMMERCIAL STATUS are offered for commercial sale only in countries where the corresponding patents or SPCs expired. In case of the countries where the products are protected by valid patents or SPCs in force they are listed only for purposes reasonably related to conducting research, development and regulatory procedures provided for by Bolar-type exemption in the target country. It is within the partner´s responsibility and liability to check the patent situation of the product in the target market(s).

OK